BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8284102)

  • 1. Sulfonylurea receptor expression in rat brain: effect of chronic hypoxia during development.
    Xia Y; Eisenman D; Haddad GG
    Pediatr Res; 1993 Nov; 34(5):634-41. PubMed ID: 8284102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major differences in CNS sulfonylurea receptor distribution between the rat (newborn, adult) and turtle.
    Xia Y; Haddad GG
    J Comp Neurol; 1991 Dec; 314(2):278-89. PubMed ID: 1787178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonylurea binding sites associated with ATP-regulated K+ channels in the central nervous system: autoradiographic analysis of their distribution and ontogenesis, and of their localization in mutant mice cerebellum.
    Mourre C; Widmann C; Lazdunski M
    Brain Res; 1990 Jun; 519(1-2):29-43. PubMed ID: 2118822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro regulation of [3H]glyburide binding to brain sulfonylurea receptors in obesity-prone and resistant rats by glucose.
    Levin BE; Dunn-Meynell AA
    Brain Res; 1997 Nov; 776(1-2):146-53. PubMed ID: 9439807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of diet and obesity on high and low affinity sulfonylurea binding sites in the rat brain.
    Levin BE; Brown KL; Dunn-Meynell AA
    Brain Res; 1996 Nov; 739(1-2):293-300. PubMed ID: 8955950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.
    Zhou Y; Fathali N; Lekic T; Tang J; Zhang JH
    Brain Res; 2009 May; 1270():131-9. PubMed ID: 19306849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel simple method for the investigation of drug binding to the K(ATP) channel sulfonylurea receptor.
    Mikhailova EA; Ashcroft SJ; Mikhailov MV
    Anal Biochem; 2002 Aug; 307(2):383-5. PubMed ID: 12202259
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the rat mesangial cell type 2 sulfonylurea receptor.
    Asano K; Cortes P; Garvin JL; Riser BL; Rodríguez-Barbero A; Szamosfalvi B; Yee J
    Kidney Int; 1999 Jun; 55(6):2289-98. PubMed ID: 10354277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.
    Ammälä C; Moorhouse A; Gribble F; Ashfield R; Proks P; Smith PA; Sakura H; Coles B; Ashcroft SJ; Ashcroft FM
    Nature; 1996 Feb; 379(6565):545-8. PubMed ID: 8596634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfonylurea receptors].
    Huupponen R
    Duodecim; 1989; 105(19):1578-80. PubMed ID: 2553390
    [No Abstract]   [Full Text] [Related]  

  • 11. The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP.
    Schwanstecher M; Behrends S; Brandt C; Panten U
    J Pharmacol Exp Ther; 1992 Aug; 262(2):495-502. PubMed ID: 1501109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
    Kramer W; Oekonomopulos R; Pünter J; Summ HD
    FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-sensitive Na+ channels increase in number in newborn rat brain after in utero hypoxia.
    Xia Y; Haddad GG
    Brain Res; 1994 Jan; 635(1-2):339-44. PubMed ID: 8173974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [(3)H]Glyburide binding with opiate analgesia, tolerance, and dependence in ICR and Swiss-Webster mice.
    Campbell VC; Dewey WL; Welch SP
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1112-9. PubMed ID: 11082447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease?
    Hoyer S; Lee SK; Löffler T; Schliebs R
    Ann N Y Acad Sci; 2000; 920():256-8. PubMed ID: 11193160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor.
    Tricarico D; Barbieri M; Camerino DC
    Br J Pharmacol; 2000 Jun; 130(4):827-34. PubMed ID: 10864889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
    Gopalakrishnan M; Molinari EJ; Shieh CC; Monteggia LM; Roch JM; Whiteaker KL; Scott VE; Sullivan JP; Brioni JD
    Br J Pharmacol; 2000 Apr; 129(7):1323-32. PubMed ID: 10742287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.